1,25 (Oh)2 Vitamin D3 Modifies Growth and Contractile Function of Vascular Smooth Muscle of Spontaneously Hypertensive Rats

American Journal of Hypertension

Volumn 2, Issue 7, 1989, Pages 553-556

  Bukoski, Richard D ^a   Dewan, Peggy ^a   McCarron, David A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cultured Vascular Myocytes; Mesenteric Resistance Arteries; Norepinephrine; Spontaneously Hypertensive Rat; Wistar Kyoto Rat

Indexed keywords

COLECALCIFEROL; NORADRENALIN;

ANIMAL CELL; CELL CULTURE; HYPERTENSION; NONHUMAN; VASCULAR SMOOTH MUSCLE;

ANIMAL; CALCITRIOL; CELL DIVISION; CELLS, CULTURED; HYPERTENSION; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024403995     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/2.7.553     Document Type: Article

References (18)

1. 3 receptors: gene regulation and genetic circuitry. FASEB J 1988; 2: 3043-3053.
2. 45Ca uptake by primary cultures of aortic myocytes of spontaneously hypertensive and Wistar-Kyoto normotensive rats. Biochem Biophys Res Comm 1987; 147: 1330-1335.
3. 45Ca uptake by aortic myocytes of the spontaneously hypertensive and Wistar-Kyoto normotensive rat in long-term culture. FASEB J 1988; 2(5): A966.
4. 2+ -uptake by cultured vascular smooth muscle cells derived from rat aorta. Biochem Biophys Res Comm 1988; 152: 1388-1394.
5. 3 receptors and actions in vascular smooth muscle in vitro. Calcif Tiss Int 1987; 41: 112-114.
6. Kawashima H: Receptor for 1,25 dihydroxy vitamin D in a vascular cell line derived from rat aorta. Biochem Biophys Res Comm 1987; 146: 1-6.
7. 3 in the murine myeolmonocytic leukemia cell line WEHI-3. Cancer Res 1986; 46: 6316-6321.
8. 3 induces anchorage independent growth and c-Ki-ras expression of BALB/33T3 and NIH/3T3 cells. Jpn J Cancer Res 1987; 78: 99-102.
9. 3 increases epidermal growth factor receptors and transforming growth factor-like activity in a bone-derived cell line. J Biol Chem 1987; 262: 13424-13428.
10. Folkow B: Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347-504.
11. Owens GK, Schwartz SM, McCarra M: Evaluation of medial hypertrophy in resistance vessels of spontaneously hypertensive rats. Hypertension 1988; 11: 198-207.
12. Bukoski RD, Xue H, DeWan et al P,: Calciotropic hormones and vascular calcium metabolism in experimental hypertension, in Halpern W, Pegram B, Brayden J, et al (eds): Second International Symposium on Resistance Arteries. Ithaca, NY, Perinatology Press, 1988, p 320-328.
13. Mulvany MJ, Halpern W: Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26.
14. Takasu N, Takasu M, Yamada et al T,: Epidermal growth factor (EGF) produces inositol phosphates and increases cytoplasmic free calcium in cultured porcine thyroid cells. Biochem Biophys Res Comm 1988; 151: 530-534.
15. Moolenar WH, Aerts RJ, Tertoolen et al LGJ,: The epidermal growth factor-induced calcium signal in A341 cells. J Biol Chem 1986; 261: 279-284.
16. Schedl HP, Wilson HD, Horst RL: Calcium transport and vitamin D in three breeds of spontaneously hypertensive rats. Hypertension 1988; 12: 310-316.
17. Young E, Bukoski RD, McCarron DA: Calcium metabolism in experimental hypertension. Proc Soc Exp Biol Med 1988; 187: 123-141.
18. 3 by calcium and phosphate in the rat. Science 1975; 190: 578-580.